Emerging therapies for peanut allergy focus on novel immunotherapies like epicutaneous patches, peptide mixtures, and nanoparticle-based vaccines. These approaches offer potential for improved safety ...

The "Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" report highlights significant R&D opportunities with over 20 companies and 22 pipeline drugs, focusing on innovative treatments like ...

The sodium channel blockers market presents opportunities in treating conditions like arrhythmias, epilepsy, and neuropathic pain due to their action on sodium channels. Emerging drugs, like evenamide ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

The Atopic Dermatitis Pipeline Report provides disease overview, pipeline scenario and therapeutic assessment of the key ...

Non-Alcoholic Steatohepatitis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present ...

At a recent hearing on Capitol Hill, FBI Director Kash Patel celebrated the Trump administration's labeling of drug cartels as foreign terrorist organizations, and told lawmakers the United States ...

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

The Trump administration has yet to provide underlying evidence to lawmakers proving that alleged drug-smuggling boats targeted by the U.S. military in a series of fatal strikes were in fact carrying ...

Still given JNJ has most of the rights to market and sell icontrokinra, is there any pressing need to complete a full, ...

This study reviewed all industry-sponsored phase I clinical trial protocols activated at one of eight Sarah Cannon Research Institute drug development units between 2021 and 2024. The review focused ...